Haloperidol modifies instrumental aspects of slot machine gambling in pathological gamblers and healthy controls
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Haloperidol modifies instrumental aspects of slot machine gambling in pathological gamblers and healthy controls
Authors
Keywords
-
Journal
ADDICTION BIOLOGY
Volume 16, Issue 3, Pages 467-484
Publisher
Wiley
Online
2010-03-10
DOI
10.1111/j.1369-1600.2010.00208.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study
- (2009) T. D. L. Steeves et al. BRAIN
- Olanzapine in the Treatment of Pathological Gambling
- (2009) Susan L. McElroy et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Basolateral Amygdala Is Critical to the Expression of Pavlovian and Instrumental Outcome-Specific Reinforcer Devaluation Effects
- (2009) A. W. Johnson et al. JOURNAL OF NEUROSCIENCE
- Dopaminergic Response to Drug Words in Cocaine Addiction
- (2009) R. Z. Goldstein et al. JOURNAL OF NEUROSCIENCE
- Frequency of New-Onset Pathologic Compulsive Gambling or Hypersexuality After Drug Treatment of Idiopathic Parkinson Disease
- (2009) J. Michael Bostwick et al. MAYO CLINIC PROCEEDINGS
- Disulfiram, an old drug with new potential in the treatment of pathological gambling?
- (2009) Jochen Mutschler et al. MEDICAL HYPOTHESES
- Dopamine receptors in the learning, memory and drug reward circuitry
- (2009) Jeffrey W. Dalley et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Dopaminergic and non-dopaminergic value systems in conditioning and outcome-specific revaluation
- (2008) Mark R. Dranias et al. BRAIN RESEARCH
- Reduced posterior mesofrontal cortex activation by risky rewards in substance-dependent patients
- (2008) James M. Bjork et al. DRUG AND ALCOHOL DEPENDENCE
- Single dose of a dopamine agonist impairs reinforcement learning in humans: Evidence from event-related potentials and computational modeling of striatal-cortical function
- (2008) Diane L. Santesso et al. HUMAN BRAIN MAPPING
- Mesolimbic Functional Magnetic Resonance Imaging Activations during Reward Anticipation Correlate with Reward-Related Ventral Striatal Dopamine Release
- (2008) B. H. Schott et al. JOURNAL OF NEUROSCIENCE
- Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity
- (2008) M Zack et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Dopamine D1 and D2 receptors in the nucleus accumbens core and shell mediate Pavlovian-instrumental transfer
- (2008) A. Lex et al. LEARNING & MEMORY
- A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers
- (2008) Timothy Fong et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The neurobiology of pathological gambling and drug addiction: an overview and new findings
- (2008) M. N Potenza PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Dopamine Agonist Increases Risk Taking but Blunts Reward-Related Brain Activity
- (2008) Jordi Riba et al. PLoS One
- Characteristics of Black and White Callers to a Gambling Helpline
- (2008) D. T. Barry et al. PSYCHIATRIC SERVICES
- DSM-IV pathological gambling in the National Comorbidity Survey Replication
- (2008) R. C. Kessler et al. PSYCHOLOGICAL MEDICINE
- Predicting response to opiate antagonists and placebo in the treatment of pathological gambling
- (2008) Jon E. Grant et al. PSYCHOPHARMACOLOGY
- D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats
- (2008) Panayotis K. Thanos et al. SYNAPSE
- A top-down perspective on dopamine, motivation and memory
- (2007) Anthony G. Phillips et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More